BVF Inc
- SEC CIK
- 0001056807
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 83
- +8 vs. Q3 2021
- Portfolio value
- $2.76B
- +$192.0M (+7.5%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| GHRSGH Research PLC | ORDINARY SHARES | 9,275,158 | $216.4M | 7.9% | 00.0% | Unchanged | History |
| KYMRKymera Therapeutics, Inc. | COM | 3,180,658 | $201.9M | 7.3% | 00.0% | Unchanged | History |
| RCUSArcus Biosciences, Inc. | COM | 3,398,067 | $137.5M | 5.0% | +168,245+5.2% | Added | History |
| MRUSMerus N.V. | COM | 4,135,071 | $131.5M | 4.8% | +4,135,071 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 3,651,759 | $124.9M | 4.5% | −250,000−6.4% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 3,289,540 | $102.8M | 3.7% | +1,717,762+109.3% | Added | History |
| RPTXRepare Therapeutics Inc. | COM | 4,858,761 | $102.5M | 3.7% | +1,136,363+30.5% | Added | History |
| RLAYRelay Therapeutics, Inc. | COM | 3,130,605 | $96.1M | 3.5% | +1,081,492+52.8% | Added | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 3,003,879 | $85.3M | 3.1% | +2,050,000+214.9% | Added | History |
| CGEMCullinan Therapeutics, Inc. | COM | 5,369,459 | $82.9M | 3.0% | +4,634,353+630.4% | Added | History |
| ARGXArgenx SE | SPONSORED ADR | 216,204 | $75.7M | 2.7% | −150,000−41.0% | Reduced | History |
| XOMAXOMA Royalty Corp | COM NEW | 3,530,543 | $73.6M | 2.7% | 00.0% | Unchanged | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 7,411,503 | $69.4M | 2.5% | +750,000+11.3% | Added | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 1,156,393 | $63.8M | 2.3% | +36,660+3.3% | Added | History |
| LXRXLexicon Pharmaceuticals, Inc. | COM NEW | 14,360,000 | $56.6M | 2.1% | 00.0% | Unchanged | History |
| AMRNAmarin Corp PLC | SPONS ADR NEW | 16,459,965 | $55.5M | 2.0% | +5,052,783+44.3% | Added | History |
| EQRXEQRx, Inc. | COM | 7,859,670 | $53.6M | 1.9% | +7,859,670 | New | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 2,099,714 | $46.0M | 1.7% | −386,715−15.6% | Reduced | History |
| RVMDRevolution Medicines, Inc. | COM | 1,810,549 | $45.6M | 1.7% | −674,500−27.1% | Reduced | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,005,862 | $44.0M | 1.6% | 00.0% | Unchanged | History |
| EPIXESSA Pharma Inc. | COM NEW | 2,851,461 | $40.5M | 1.5% | 00.0% | Unchanged | History |
| Rain Oncology Inc.75082Q105 | COM | 2,957,807 | $38.1M | 1.4% | 00.0% | Unchanged | – |
| VRDNViridian Therapeutics, Inc. | COM | 1,879,412 | $37.2M | 1.3% | +1,075,286+133.7% | Added | History |
| RLMDRelmada Therapeutics, Inc. | COM | 1,647,400 | $37.1M | 1.3% | +1,647,400 | New | History |
| VSTMVerastem, Inc. | COM | 17,062,158 | $35.0M | 1.3% | +2,084,900+13.9% | Added | History |
| ACIUAC Immune SA | SHS | 7,062,379 | $35.0M | 1.3% | +127,200+1.8% | Added | History |
| KDNYChinook Therapeutics, Inc. | COM | 1,800,000 | $29.4M | 1.1% | +1,800,000 | New | History |
| KURAKura Oncology, Inc. | COM | 2,064,212 | $28.9M | 1.0% | +429,100+26.2% | Added | History |
| TYRATyra Biosciences, Inc. | COM | 1,873,332 | $26.4M | 1.0% | +178,399+10.5% | Added | History |
| SPROSpero Therapeutics, Inc. | COM | 1,585,615 | $25.4M | 0.9% | −223,737−12.4% | Reduced | History |
| CTMXCytomX Therapeutics, Inc. | COM | 5,803,700 | $25.1M | 0.9% | +5,803,700 | New | History |
| REPLReplimune Group, Inc. | COM | 926,529 | $25.1M | 0.9% | 00.0% | Unchanged | History |
| ACRSAclaris Therapeutics, Inc. | COM | 1,695,904 | $24.7M | 0.9% | +322,860+23.5% | Added | History |
| IMAImageneBio, Inc. | COM | 1,798,371 | $22.6M | 0.8% | −33,700−1.8% | Reduced | History |
| CTICCti Biopharma Corp | COM | 8,929,690 | $22.1M | 0.8% | 00.0% | Unchanged | History |
| ALPNAlpine Immune Sciences, Inc. | COM | 1,589,495 | $22.0M | 0.8% | 00.0% | Unchanged | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 899,392 | $21.7M | 0.8% | −247,660−21.6% | Reduced | History |
| OVIDOvid Therapeutics Inc. | COM | 6,631,051 | $21.3M | 0.8% | 00.0% | Unchanged | History |
| Pieris Pharmaceuticals Inc720795103 | COM | 5,328,239 | $20.1M | 0.7% | 00.0% | Unchanged | – |
| JANXJanux Therapeutics, Inc. | COM | 1,017,314 | $20.1M | 0.7% | 00.0% | Unchanged | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 1,791,351 | $19.7M | 0.7% | +1,791,351 | New | History |
| Calliditas Therapeutics AB13124Q106 | SPONSERED ADS | 750,000 | $18.6M | 0.7% | 00.0% | Unchanged | – |
| NGMNGM Biopharmaceuticals Inc | COM | 955,000 | $16.9M | 0.6% | 00.0% | Unchanged | History |
| PNTPOINT Biopharma Global Inc. | COM | 2,920,526 | $16.4M | 0.6% | +148,300+5.3% | Added | History |
| SLNSilence Therapeutics plc | ADS | 666,666 | $15.6M | 0.6% | 00.0% | Unchanged | History |
| INFIInfinity Pharmaceuticals, Inc. | COM | 6,353,645 | $14.3M | 0.5% | −2,030,000−24.2% | Reduced | History |
| STROSutro Biopharma, Inc. | COM | 925,148 | $13.8M | 0.5% | +98,323+11.9% | Added | History |
| CBIOCrescent Biopharma, Inc. | COM | 9,544,262 | $13.7M | 0.5% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 809,282 | $13.6M | 0.5% | −1,002−0.1% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 1,532,282 | $13.1M | 0.5% | 00.0% | Unchanged | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,438,944 | $12.6M | 0.5% | +344,770+11.1% | Added | History |
| MTEMMolecular Templates, Inc. | COM | 3,129,599 | $12.3M | 0.4% | +273,000+9.6% | Added | History |
| CFRXCONTRAFECT Corp | COM NEW | 3,972,300 | $10.4M | 0.4% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 1,611,698 | $9.70M | 0.4% | +21,400+1.3% | Added | History |
| LITSLite Strategy, Inc. | COM NEW | 3,532,057 | $9.43M | 0.3% | 00.0% | Unchanged | History |
| CDTXCidara Therapeutics, Inc. | COM | 6,861,127 | $8.71M | 0.3% | +2,084,223+43.6% | Added | History |
| MOLNMolecular Partners AG | ADS | 443,221 | $8.55M | 0.3% | +24,213+5.8% | Added | History |
| NUVLNuvalent, Inc. | COM | 448,512 | $8.54M | 0.3% | 00.0% | Unchanged | History |
| IVAInventiva S.A. | ADS | 544,500 | $7.44M | 0.3% | 00.0% | Unchanged | History |
| CNCEConcert Pharmaceuticals, Inc. | COM | 2,253,000 | $7.10M | 0.3% | +2,253,000 | New | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 435,936 | $6.95M | 0.3% | 00.0% | Unchanged | History |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,378,020 | $6.08M | 0.2% | +14,585+1.1% | Added | History |
| RNACCartesian Therapeutics, Inc. | COM | 1,723,133 | $5.62M | 0.2% | +1,403,455+439.0% | Added | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 454,545 | $5.12M | 0.2% | +454,545 | New | History |
| Eucrates Biomedical Acqu CorG3141W114 | UNIT 10/23/2027 | 500,000 | $4.99M | 0.2% | 00.0% | Unchanged | – |
| CALACalithera Biosciences, Inc. | COM | 7,452,331 | $4.96M | 0.2% | 00.0% | Unchanged | History |
| Frazier Lifesciences Acqu CoG3710A121 | UNIT 12/09/2025 | 500,000 | $4.95M | 0.2% | 00.0% | Unchanged | – |
| 5 01 Acquisition Corp33836P105 | COM CL A | 500,000 | $4.92M | 0.2% | 00.0% | Unchanged | – |
| RACBResearch Alliance Corp. II | COM CL A | 500,000 | $4.86M | 0.2% | 00.0% | Unchanged | History |
| GNCAGenocea Biosciences, Inc. | COM NEW | 4,012,404 | $4.65M | 0.2% | 00.0% | Unchanged | History |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 1,370,947 | $3.30M | 0.1% | 00.0% | Unchanged | History |
| EOCNGalmed Pharmaceuticals Ltd. | SHS | 1,799,694 | $3.27M | 0.1% | 00.0% | Unchanged | History |
| ELTXElicio Therapeutics, Inc. | COM | 1,071,297 | $3.11M | 0.1% | 00.0% | Unchanged | History |
| Erytech Pharma29604W108 | SPONSORED ADR | 1,314,656 | $3.10M | 0.1% | 00.0% | Unchanged | – |
| RNTXRein Therapeutics, Inc. | COM | 5,265,555 | $2.96M | 0.1% | 00.0% | Unchanged | History |
| JYACJiya Acquisition Corp. | COM CL A | 300,000 | $2.93M | 0.1% | 00.0% | Unchanged | History |
| Forward Pharma A/S34986J204 | SPONSORD ADS NEW | 432,892 | $2.58M | 0.1% | 00.0% | Unchanged | – |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 289,663 | $1.96M | 0.1% | 00.0% | Unchanged | History |
| XFORX4 Pharmaceuticals, Inc | COM | 847,879 | $1.94M | 0.1% | 00.0% | Unchanged | History |
| GBIOGeneration Bio Co. | COM | 189,050 | $1.34M | <0.1% | +189,050 | New | History |
| BNOXBionomics Ltd | ADS | 80,971 | $1.02M | <0.1% | +80,971 | New | History |
| RZLTRezolute, Inc. | COM NEW | 190,815 | $912.0K | <0.1% | 00.0% | Unchanged | History |
| VYGRVoyager Therapeutics, Inc. | COM | 22,200 | $60.0K | <0.1% | +22,200 | New | History |
Sold out since Q3 2021 (3)
Positions held at the end of Q3 2021 that are gone from this filing.